+43 316 269 205 office@innophore.com

ABOUT US

VISION

 

The R&D vision of Innophore is to identify high-value industrial and therapeutic enzymes and to develop and identify enzymes for more efficient, green chemical production processes and novel biosimilars for medical treatments.

Furthermore, we strive to make important contributions to the re-purposing of drugs as well as the prediction of drug side effects with the help of our 3D point cloud technology.

TEAM

Dr. Christian Gruber

Dr. Christian Gruber

CEO

Dr. Georg Steinkellner

Dr. Georg Steinkellner

CTO

Prof. Karl Gruber

Prof. Karl Gruber

CSO

Christian Gruber, MSc.

Christian Gruber, MSc.

CFO

DI Christopher Trummer

DI Christopher Trummer

Business Development

Dr. Vedat Durmaz

Dr. Vedat Durmaz

Senior Researcher

Alice Guarneri

Alice Guarneri

PhD Student

Daniel Nutz

Daniel Nutz

Data Scientist

Klara Blaschitz

Klara Blaschitz

Researcher

Innophore GmbH is a spin-off company of acib GmbH and University of Graz and was supported as founding project by Science Park Graz GmbH in the framework of the AplusB program.

Innophore GmbH is supported by the strategic investor EOSS Industries GmbH.